(19)

(11)

EP 4 294 469 A1

(12)

(43) Date of publication: 27.12.2023 Bulletin 2023/52 (21) Application number: 22709167.5 (22) Date of filing: 22.02.2022

(51) International Patent Classification (IPC):  A61L 27/06(2006.01) A61L 27/38(2006.01) A61B 17/00(2006.01) A61L 27/36(2006.01) A61L 31/02(2006.01) A61F 5/00(2006.01) (52) Cooperative Patent Classification (CPC): A61L 31/022; A61B 17/00; A61F 5/00; A61L 31/005; A61L 31/16; A61L 2300/30; A61L 2300/64; A61L 2430/22 (86) International application number: PCT/US2022/070759 (87) International publication number: WO 2022/178555 (25.08.2022 Gazette 2022/34)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 22.02.2021 US 202163200212 P (71) Applicants: Biomedix S.A. 1201 Geneva (CH) Godin, Norman 1201 Geneva (CH)	(72) Inventor: GODIN, Norman 1201 Geneva (CH) (74) Representative: Sterling IP  Orion House Bessemer Road Welwyn Garden City AL7 1HH Welwyn Garden City AL7 1HH (GB)